XK
PTCT icon

Xact Kapitalforvaltning’s PTC Therapeutics PTCT Stock Holding History

Xact Kapitalforvaltning’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$366K Hold
8,200
– – 0.01% 899
2019
Q4 		$394K Hold
8,200
– – 0.01% 1112
2019
Q3 		$277K Hold
8,200
– – 0.01% 1234
2019
Q2 		$369K Hold
8,200
– – 0.01% 1104
2019
Q1 		$309K Hold
8,200
– – 0.01% 1205
2018
Q4 		$281K Buy
8,200
+1,800
+28% +$64.7K 0.01% 1271
2018
Q3 		$301K Hold
6,400
– – 0.01% 1365
2018
Q2 		$216K Buy
+6,400
New +$200K ﹤0.01% 1516

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Xact Kapitalforvaltning's PTCT Position: Q1 2020 in Review

Xact Kapitalforvaltning held its PTC Therapeutics (PTCT) position steady in Q1 2020 at 8,200 shares worth $366K. The position accounts for 0.01% of the portfolio, ranked #899.

Xact Kapitalforvaltning first reported a position in PTCT in Q2 2018 and has held it in 8 quarters since. The position peaked at $394K in Q4 2019. 203 funds tracked by Wall St. Rank hold PTCT as of Q1 2020.

  • Xact Kapitalforvaltning held 8,200 shares of PTC Therapeutics worth $366K as of Q1 2020.
  • Xact Kapitalforvaltning left its PTC Therapeutics share count unchanged in Q1 2020.
  • PTC Therapeutics made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #899 holding.
  • Xact Kapitalforvaltning first reported a position in PTC Therapeutics in Q2 2018 and has held it in 8 quarters since.
  • Xact Kapitalforvaltning's PTC Therapeutics position peaked at $394K in Q4 2019.
  • 203 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.